What is CVE-2023-38955?

CVE-2023-38955 is a high-severity vulnerability in Zkteco Bioaccess Ivs, classified under Exposure of Resource to Wrong Sphere. CVSS score: 7.5/10. Published 2023-08-03.

How severe is CVE-2023-38955?

High severity. CVSS v3 base score is 7.5 out of 10.

Vulnerability in Zkteco Bioaccess Ivs

CVE-2023-38955

ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.

EPSS: 0.005 (39.8th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.

Affected products

Zkteco Bioaccess_ivs — versions 3.3.1
N/a — versions n/a

Weakness classification (CWE)

CWE-668 — Exposure of Resource to Wrong Sphere

References

af854a3a-2127-422b-91ae-364da2661108 (Not Applicable)
cve@mitre.org (Third Party Advisory)

Frequently asked questions

What is CVE-2023-38955?: CVE-2023-38955 is a high-severity vulnerability in Zkteco Bioaccess Ivs, classified under Exposure of Resource to Wrong Sphere. CVSS score: 7.5/10. Published 2023-08-03.
How severe is CVE-2023-38955?: High severity. CVSS v3 base score is 7.5 out of 10.